Goldenwell Biotech (GWLL) Retained Earnings (2019 - 2025)
Goldenwell Biotech's Retained Earnings history spans 7 years, with the latest figure at -$1.4 million for Q3 2025.
- For Q3 2025, Retained Earnings fell 5.68% year-over-year to -$1.4 million; the TTM value through Sep 2025 reached -$1.4 million, down 5.68%, while the annual FY2024 figure was -$1.4 million, 10.71% down from the prior year.
- Retained Earnings reached -$1.4 million in Q3 2025 per GWLL's latest filing, down from -$1.4 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$54810.0 in Q1 2021 to a low of -$1.4 million in Q3 2025.
- Average Retained Earnings over 5 years is -$853217.5, with a median of -$1.2 million recorded in 2023.
- Peak YoY movement for Retained Earnings: crashed 1598.76% in 2021, then dropped 5.68% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$125690.0 in 2021, then plummeted by 783.75% to -$1.1 million in 2022, then dropped by 10.57% to -$1.2 million in 2023, then dropped by 10.71% to -$1.4 million in 2024, then dropped by 3.5% to -$1.4 million in 2025.
- Per Business Quant, the three most recent readings for GWLL's Retained Earnings are -$1.4 million (Q3 2025), -$1.4 million (Q2 2025), and -$1.4 million (Q1 2025).